vs

Side-by-side financial comparison of Flywire Corp (FLYW) and REPLIGEN CORP (RGEN). Click either name above to swap in a different company.

REPLIGEN CORP is the larger business by last-quarter revenue ($197.9M vs $157.5M, roughly 1.3× Flywire Corp). REPLIGEN CORP runs the higher net margin — 6.7% vs 0.0%, a 6.7% gap on every dollar of revenue. On growth, Flywire Corp posted the faster year-over-year revenue change (34.0% vs 13.6%). REPLIGEN CORP produced more free cash flow last quarter ($17.6M vs $4.5M). Over the past eight quarters, Flywire Corp's revenue compounded faster (17.5% CAGR vs 14.4%).

Flywire Corp is a global payment and receivables solutions provider serving core verticals including education, healthcare, travel, and B2B commerce. It offers secure cross-border payment processing, currency conversion, and workflow tools for organizations and payers worldwide.

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

FLYW vs RGEN — Head-to-Head

Bigger by revenue
RGEN
RGEN
1.3× larger
RGEN
$197.9M
$157.5M
FLYW
Growing faster (revenue YoY)
FLYW
FLYW
+20.4% gap
FLYW
34.0%
13.6%
RGEN
Higher net margin
RGEN
RGEN
6.7% more per $
RGEN
6.7%
0.0%
FLYW
More free cash flow
RGEN
RGEN
$13.1M more FCF
RGEN
$17.6M
$4.5M
FLYW
Faster 2-yr revenue CAGR
FLYW
FLYW
Annualised
FLYW
17.5%
14.4%
RGEN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FLYW
FLYW
RGEN
RGEN
Revenue
$157.5M
$197.9M
Net Profit
$33.0K
$13.3M
Gross Margin
52.5%
Operating Margin
-0.6%
9.0%
Net Margin
0.0%
6.7%
Revenue YoY
34.0%
13.6%
Net Profit YoY
100.2%
143.9%
EPS (diluted)
$0.01
$0.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FLYW
FLYW
RGEN
RGEN
Q4 25
$157.5M
$197.9M
Q3 25
$200.1M
$188.8M
Q2 25
$131.9M
$182.4M
Q1 25
$133.5M
$169.2M
Q4 24
$117.5M
$174.1M
Q3 24
$156.8M
$154.9M
Q2 24
$103.7M
$154.1M
Q1 24
$114.1M
$151.3M
Net Profit
FLYW
FLYW
RGEN
RGEN
Q4 25
$33.0K
$13.3M
Q3 25
$29.6M
$14.9M
Q2 25
$-12.0M
$14.9M
Q1 25
$-4.2M
$5.8M
Q4 24
$-15.9M
$-30.3M
Q3 24
$38.9M
$-654.0K
Q2 24
$-13.9M
$3.3M
Q1 24
$-6.2M
$2.1M
Gross Margin
FLYW
FLYW
RGEN
RGEN
Q4 25
52.5%
Q3 25
53.2%
Q2 25
50.0%
Q1 25
53.6%
Q4 24
26.1%
Q3 24
50.0%
Q2 24
49.8%
Q1 24
49.5%
Operating Margin
FLYW
FLYW
RGEN
RGEN
Q4 25
-0.6%
9.0%
Q3 25
16.1%
8.9%
Q2 25
-6.8%
7.6%
Q1 25
-8.2%
3.9%
Q4 24
-4.9%
-17.7%
Q3 24
12.9%
-5.1%
Q2 24
-15.2%
1.0%
Q1 24
-5.2%
1.3%
Net Margin
FLYW
FLYW
RGEN
RGEN
Q4 25
0.0%
6.7%
Q3 25
14.8%
7.9%
Q2 25
-9.1%
8.2%
Q1 25
-3.1%
3.4%
Q4 24
-13.5%
-17.4%
Q3 24
24.8%
-0.4%
Q2 24
-13.4%
2.2%
Q1 24
-5.4%
1.4%
EPS (diluted)
FLYW
FLYW
RGEN
RGEN
Q4 25
$0.01
$0.24
Q3 25
$0.23
$0.26
Q2 25
$-0.10
$0.26
Q1 25
$-0.03
$0.10
Q4 24
$-0.12
$-0.55
Q3 24
$0.30
$-0.01
Q2 24
$-0.11
$0.06
Q1 24
$-0.05
$0.04

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FLYW
FLYW
RGEN
RGEN
Cash + ST InvestmentsLiquidity on hand
$355.0M
$767.6M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$835.2M
$2.1B
Total Assets
$1.3B
$2.9B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FLYW
FLYW
RGEN
RGEN
Q4 25
$355.0M
$767.6M
Q3 25
$377.3M
$748.7M
Q2 25
$274.2M
$708.9M
Q1 25
$255.3M
$697.2M
Q4 24
$611.1M
$757.4M
Q3 24
$681.1M
$784.0M
Q2 24
$571.0M
$809.1M
Q1 24
$619.0M
$780.6M
Total Debt
FLYW
FLYW
RGEN
RGEN
Q4 25
$542.2M
Q3 25
$15.0M
$537.9M
Q2 25
$60.0M
Q1 25
$60.0M
Q4 24
$0
$525.6M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
FLYW
FLYW
RGEN
RGEN
Q4 25
$835.2M
$2.1B
Q3 25
$829.1M
$2.1B
Q2 25
$792.4M
$2.1B
Q1 25
$784.3M
$2.0B
Q4 24
$814.8M
$2.0B
Q3 24
$843.2M
$2.0B
Q2 24
$802.6M
$2.0B
Q1 24
$-797.0M
$2.0B
Total Assets
FLYW
FLYW
RGEN
RGEN
Q4 25
$1.3B
$2.9B
Q3 25
$1.3B
$2.9B
Q2 25
$1.1B
$2.9B
Q1 25
$1.1B
$2.9B
Q4 24
$1.1B
$2.8B
Q3 24
$1.2B
$2.8B
Q2 24
$998.7M
$2.9B
Q1 24
$998.7M
$2.8B
Debt / Equity
FLYW
FLYW
RGEN
RGEN
Q4 25
0.26×
Q3 25
0.02×
0.26×
Q2 25
0.08×
Q1 25
0.08×
Q4 24
0.00×
0.27×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FLYW
FLYW
RGEN
RGEN
Operating Cash FlowLast quarter
$4.9M
$25.7M
Free Cash FlowOCF − Capex
$4.5M
$17.6M
FCF MarginFCF / Revenue
2.9%
8.9%
Capex IntensityCapex / Revenue
0.2%
4.1%
Cash ConversionOCF / Net Profit
148.06×
1.93×
TTM Free Cash FlowTrailing 4 quarters
$98.8M
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FLYW
FLYW
RGEN
RGEN
Q4 25
$4.9M
$25.7M
Q3 25
$150.1M
$48.1M
Q2 25
$24.1M
$28.6M
Q1 25
$-78.9M
$15.0M
Q4 24
$-28.6M
$39.2M
Q3 24
$184.6M
$49.3M
Q2 24
$-19.3M
$42.2M
Q1 24
$-38.1M
$44.7M
Free Cash Flow
FLYW
FLYW
RGEN
RGEN
Q4 25
$4.5M
$17.6M
Q3 25
$149.9M
$43.4M
Q2 25
$23.5M
$21.5M
Q1 25
$-79.1M
$11.4M
Q4 24
$-28.7M
$33.6M
Q3 24
$184.4M
$42.3M
Q2 24
$-19.7M
$37.4M
Q1 24
$-38.3M
$36.4M
FCF Margin
FLYW
FLYW
RGEN
RGEN
Q4 25
2.9%
8.9%
Q3 25
74.9%
23.0%
Q2 25
17.8%
11.8%
Q1 25
-59.3%
6.8%
Q4 24
-24.4%
19.3%
Q3 24
117.6%
27.3%
Q2 24
-19.0%
24.3%
Q1 24
-33.6%
24.0%
Capex Intensity
FLYW
FLYW
RGEN
RGEN
Q4 25
0.2%
4.1%
Q3 25
0.1%
2.5%
Q2 25
0.4%
3.9%
Q1 25
0.1%
2.1%
Q4 24
0.1%
3.2%
Q3 24
0.1%
4.5%
Q2 24
0.3%
3.1%
Q1 24
0.2%
5.5%
Cash Conversion
FLYW
FLYW
RGEN
RGEN
Q4 25
148.06×
1.93×
Q3 25
5.07×
3.23×
Q2 25
1.92×
Q1 25
2.57×
Q4 24
Q3 24
4.75×
Q2 24
12.70×
Q1 24
21.35×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FLYW
FLYW

Transactions$126.4M80%
Platform And Other Revenues$31.1M20%

RGEN
RGEN

Segment breakdown not available.

Related Comparisons